Folic acid and the MTHFR gene

Folic acid is one of the most important nutrients in early pregnancy and in heart health, yet the form in most supplements is inactive until your body converts it. The gene that does the converting is MTHFR.

Folic acid has to be activated

The folic acid in standard supplements is a provitamin. Before your cells can use it, it must be converted into its active form, methylfolate. If that conversion is slow, you can take plenty of folic acid and still be functionally short of usable folate.

MTHFR is the activator

The enzyme that performs the key step is made by the MTHFR gene. Two common variants, C677T and A1298C, reduce its activity. People with two copies of C677T can have only around a third of normal enzyme activity, sharply limiting how much folic acid they activate.

Why it matters

Poor folate activation feeds into raised homocysteine (a cardiovascular risk marker), neural-tube-defect risk in pregnancy, and aspects of mood and methylation. The intake looks adequate on paper while the usable amount is not.

What actually helps

For reduced-function carriers the answer is simple: take folate as methylfolate (5-MTHF) rather than standard folic acid, supported by the cofactor B-vitamins B12, B6 and B2. It is a precise example of the right form mattering as much as the dose.

The science, in depth

MTHFR catalyses the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the methyl donor for homocysteine remethylation. C677T (Ala222Val) destabilises the enzyme, lowering activity in a genotype-dependent way, which is the rationale for direct 5-MTHF supplementation in impaired carriers.